Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin).

Cook G Jr, Parker C, Chua S, Johnson B, Aksnes AK, Lewington VJ.

EJNMMI Res. 2011 Jun 7;1(1):4. doi: 10.1186/2191-219X-1-4.

PMID:
22214491
[PubMed]
Free PMC Article
2.

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.

Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T; International Neuroblastoma Risk Group Project.

Radiology. 2011 Oct;261(1):243-57. doi: 10.1148/radiol.11101352. Epub 2011 May 17.

PMID:
21586679
[PubMed - indexed for MEDLINE]
3.

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.

Cook GJ, Venkitaraman R, Sohaib AS, Lewington VJ, Chua SC, Huddart RA, Parker CC, Dearnaley DD, Horwich A.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):7-13. doi: 10.1007/s00259-010-1576-0. Epub 2010 Aug 10.

PMID:
20697891
[PubMed - indexed for MEDLINE]
4.

Dosimetry for (90)Y-DOTATOC therapies in patients with neuroendocrine tumors.

Hindorf C, Chittenden S, Causer L, Lewington VJ, M├Ącke HR, Flux GD.

Cancer Biother Radiopharm. 2007 Feb;22(1):130-5.

PMID:
17627421
[PubMed - indexed for MEDLINE]
5.

Bone-seeking radionuclides for therapy.

Lewington VJ.

J Nucl Med. 2005 Jan;46 Suppl 1:38S-47S. Review.

PMID:
15653650
[PubMed - indexed for MEDLINE]
Free Article
6.

Targeted radionuclide therapy for neuroendocrine tumours.

Lewington VJ.

Endocr Relat Cancer. 2003 Dec;10(4):497-501. Review.

PMID:
14713264
[PubMed - indexed for MEDLINE]
Free Article
7.

A practical guide to targeted therapy for bone pain palliation.

Lewington VJ.

Nucl Med Commun. 2002 Sep;23(9):833-6.

PMID:
12195085
[PubMed - indexed for MEDLINE]
8.

Isotopic evaluation and therapy in patients with malignant endocrine disease.

Lewington VJ, Clarke SE.

Best Pract Res Clin Endocrinol Metab. 2001 Jun;15(2):225-39. Review.

PMID:
11472036
[PubMed - indexed for MEDLINE]
9.

Guidelines for the provision of physics support to nuclear medicine. Report of a Joint Working Group of the British Institute of Radiology, British Nuclear Medicine Society.

Williams NR, Tindale WB, Lewington VJ, Nunan TO, Shields RA, Thorley PJ.

Nucl Med Commun. 1999 Sep;20(9):781-7. No abstract available.

PMID:
10533182
[PubMed - indexed for MEDLINE]
10.

Radionuclide therapy.

Buchanan RB, Lewington VJ.

Clin Oncol (R Coll Radiol). 1999;11(4):219-20. No abstract available.

PMID:
10473715
[PubMed - indexed for MEDLINE]
11.

Radionuclide therapy.

Buchanan RB, Lewington VJ.

Nucl Med Commun. 1999 Aug;20(8):687. No abstract available.

PMID:
10451875
[PubMed - indexed for MEDLINE]
12.

Radionuclide therapy practice and facilities in Europe. EANM Radionuclide Therapy Committee.

Hoefnagel CA, Clarke SE, Fischer M, Chatal JF, Lewington VJ, Nilsson S, Troncone L, Vieira MR.

Eur J Nucl Med. 1999 Mar;26(3):277-82. No abstract available.

PMID:
10079320
[PubMed - indexed for MEDLINE]
13.

Cancer therapy using bone-seeking isotopes.

Lewington VJ.

Phys Med Biol. 1996 Oct;41(10):2027-42. Review.

PMID:
8912378
[PubMed - indexed for MEDLINE]
14.

Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit.

Tristam M, Alaamer AS, Fleming JS, Lewington VJ, Zivanovic MA.

J Nucl Med. 1996 Jun;37(6):1058-63.

PMID:
8683301
[PubMed - indexed for MEDLINE]
Free Article
15.

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.

Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, Reed NS, Russell JM, Yardley J.

Radiother Oncol. 1994 Apr;31(1):33-40.

PMID:
7518932
[PubMed - indexed for MEDLINE]
16.

Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.

Bolger JJ, Dearnaley DP, Kirk D, Lewington VJ, Mason MD, Quilty PM, Reed NS, Russell JM, Yardley J.

Semin Oncol. 1993 Jun;20(3 Suppl 2):32-3. No abstract available.

PMID:
7684863
[PubMed - indexed for MEDLINE]
17.

Targeted radionuclide therapy for bone metastases.

Lewington VJ.

Eur J Nucl Med. 1993 Jan;20(1):66-74. Review.

PMID:
7678397
[PubMed - indexed for MEDLINE]
18.

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

Dearnaley DP, Bayly RJ, A'Hern RP, Gadd J, Zivanovic MM, Lewington VJ.

Clin Oncol (R Coll Radiol). 1992 Mar;4(2):101-7. Review.

PMID:
1372817
[PubMed - indexed for MEDLINE]
19.

Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.

Lewington VJ, Zivanovic MA, Tristam M, McEwan AJ, Ackery DM.

J Nucl Biol Med. 1991 Oct-Dec;35(4):280-3.

PMID:
1823836
[PubMed - indexed for MEDLINE]
20.

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy.

Laing AH, Ackery DM, Bayly RJ, Buchanan RB, Lewington VJ, McEwan AJ, Macleod PM, Zivanovic MA.

Br J Radiol. 1991 Sep;64(765):816-22.

PMID:
1717094
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk